Kansas Regenerative Medicine Center
Kansas Regenerative Medicine Center is a cash-pay regenerative medicine clinic that performs autologous adipose- and bone marrow-derived stem cell therapy for orthopedic, neuropathy, autoimmune, neurological, and cardiac patients across two Kansas locations, serving consumers seeking non-surgical treatment alternatives.
- Company typePrivate
- Founded2014
- HeadquartersManhattan, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Kansas Regenerative Medicine Center does
Kansas Regenerative Medicine Center (KRMC) is a privately held regenerative medicine clinic founded in 2014 in Manhattan, Kansas, that operates as one of the only stand-alone stem cell treatment centers in the United States. The company treats patients using autologous adult mesenchymal stem cells harvested from the patient's own adipose tissue or bone marrow, combined with platelet-rich plasma (PRP), deployed via image-guided injection (C-ARM fluoroscopy for spine, ultrasound for extremities). Procedures are performed as same-day outpatient treatments under local anesthesia, with cells processed in a closed system within approximately 90 minutes, enabling multiple indications to be treated in a single visit across orthopedic, peripheral neuropathy, autoimmune, neurological, and cardiac/pulmonary conditions.
KRMC runs a direct-to-consumer, cash-pay model in which patients pay fee-for-service for procedures because insurance carriers generally classify stem cell therapy as experimental. Revenue is generated entirely from procedure fees supplemented by patient financing arranged through Bank of the Flint Hills. The company has expanded its addressable patient pool through a referral-heavy acquisition motion (more than 70% of patients arrive via referrals), digital and event-based marketing, and dedicated out-of-town patient concierge services with complimentary hotel accommodations. It operates two Kansas locations (Manhattan flagship and Leawood/Kansas City metro, opened October 2017), is affiliated with the Cell Surgical Network of 90+ physicians operating under shared IRB protocols, and in December 2023 added a Corporate Plan Management partnership targeting employer-sponsored orthopedic care.
Kansas Regenerative Medicine Center firmographics
Firmographics- Name
- Kansas Regenerative Medicine Center
- Legal name
- Kansas Regenerative Medicine Center
- Website
- https://kansasrmc.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Kansas Regenerative Medicine Center is a cash-pay regenerative medicine clinic that performs autologous adipose- and bone marrow-derived stem cell therapy for orthopedic, neuropathy, autoimmune, neurological, and cardiac patients across two Kansas locations, serving consumers seeking non-surgical treatment alternatives.
- Ownership category
- akta.pro rank
Kansas Regenerative Medicine Center industry classification
Industry- Product category
- Regenerative Medicine
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE)
- akta.pro secondary industries
- Platelet-Rich Plasma (PRP) & Blood-Derived Orthobiologics (HLAMANAB), Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ), Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics) (HLAAAGAL), Cardiovascular & Vascular Regeneration (vascular grafts, angiogenesis) (HLAAAGAJ)
Keywords
Where Kansas Regenerative Medicine Center is headquartered
LocationHeadquarters
- HQ city
- Manhattan
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Kansas Regenerative Medicine Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Stem Cell Therapy Procedures: Fee-for-service model where patients pay for stem cell treatment procedures. Cost varies depending on disease state and type of stem cell deployment. Insurance generally does not cover treatment as it is considered experimental. Medical financing available through Bank of the Flint Hills.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Free consultation for qualified candidates |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Kansas Regenerative Medicine Center product offering
Product offeringCore offering
Kansas Regenerative Medicine Center is a stand-alone regenerative medicine clinic that delivers same-day outpatient stem cell therapy using patients' own (autologous) adult mesenchymal stem cells derived from adipose (fat) tissue or bone marrow, often combined with platelet-rich plasma (PRP). Treatments target orthopedic, neurological, autoimmune, cardiac, pulmonary, and peripheral neuropathy conditions through image-guided injections under local anesthesia.
Product overview
Kansas Regenerative Medicine Center operates as a specialized regenerative medicine clinic offering stem cell therapy as its primary treatment. The center uses the patient's own adult mesenchymal stem cells (adipose-derived and bone marrow-derived) along with platelet-rich plasma therapy. The core Stem Cell Therapy offering is supported by condition-specific modules targeting knees, shoulders, back/neck, hips, feet/ankles, elbows, hands/wrists, neurology, autoimmune diseases, and cardiac/pulmonary conditions. An 8-week Peripheral Neuropathy Treatment Program provides specialized nerve repair care. Additional services include an Educational Webinars platform and a Patient Outcomes platform showcasing treatment results. All treatments are minimally invasive, outpatient procedures using local anesthesia.
Differentiator
Problem solved
Functional benefit
Products and services
- Stem Cell Therapy Primary regenerative medicine treatment using the patient's own adult mesenchymal stem cells (adipose-derived or bone marrow-derived) to accelerate healing, reduce inflammation, and promote tissue regeneration across orthopedic, neurological, autoimmune, and cardiac/pulmonary conditions.
- PRP (Platelet Rich Plasma) Therapy Blood-derived platelet-rich plasma therapy used to enhance stem cell treatments and support tissue healing, often combined with stem cell deployment for orthopedic and urologic conditions.
- Peripheral Neuropathy Treatment Program Specialized eight-week structured treatment program for peripheral neuropathy using regenerative approaches to address nerve damage, pain, numbness, and tingling in hands and feet.
- Stem Cell Therapy for Knees Specialized stem cell treatment targeting knee conditions including knee arthritis, meniscus tears, tendon and ligament tears, and overuse injuries, with the goal of avoiding knee replacement surgery.
- Stem Cell Therapy for Shoulders Regenerative treatment for shoulder conditions including partial rotator cuff tears, arthritis, labral tears, rotator cuff tendonitis, and AC joint injuries.
- Stem Cell Therapy for Back and Neck Treatment for back and spine conditions including spinal stenosis, degenerative disc disease, bulging discs, facet arthropathy, and chronic back pain, delivered via fluoroscopy-guided injections.
- Stem Cell Therapy for Neurology Neurological treatment program for multiple sclerosis (MS), ALS, Parkinson's, muscular dystrophy, stroke, spinal cord injury, traumatic brain injury, cerebral palsy, and other neurological conditions.
Quantifiable outcome
- 4,000+ patients treated successfully
- +1 more outcomes
Companies that use Kansas Regenerative Medicine Center
Customer profileNamed customers13 records
Segments6 records
Ideal customer profiles3 records
Kansas Regenerative Medicine Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Kansas Regenerative Medicine Center partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and supporting.
- Cell Surgical NetworkcoreKRMC is an affiliate of Cell Surgical Network, which has more than 90 of the world's top multidisciplinary physicians working together under the same Institutional Review Board protocols. Network members share best practices and assist each other with unique cases.
- Corporate Plan Management, Inc.supportingPartnership announced December 2023 for 70% savings expected on treating orthopedic injuries, combining KRMC's stem cell therapy with Corporate Plan Management's cost management solutions.
- Sheraton Overland Park HotelsupportingProvides free hotel rooms for patients traveling to Kansas City location for treatment as a patient benefit.
- Bluemont HotelsupportingProvides free hotel rooms for patients traveling to Manhattan location for treatment as a patient benefit.
- Eric AlbarracinsupportingWorld-class wrestling coach who refers elite MMA athletes including the Nogueira Brothers and Patricio 'Pitbull' Freire to KRMC for stem cell treatments.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Kansas Regenerative Medicine Center competitors and assessment
Company assessmentBroad incumbents
- Cleveland Clinic Center for Regenerative Medicine: Cleveland Clinic operates a dedicated regenerative medicine program offering stem cell and PRP therapies within a major academic medical system. As a broad incumbent, it represents institutional competition for legitimacy, clinical evidence, and orthopedic patient referrals.
- Hospital for Special Surgery (HSS): HSS is a leading U.S. orthopedic hospital that increasingly invests in regenerative medicine research and biologic therapies. While not a direct cash-pay clinic competitor, it is a broad incumbent shaping the orthopedic and biologic therapy landscape in which KRMC operates.
- Cell Surgical Network: Cell Surgical Network is the IRB-governed consortium of 90+ physicians to which KRMC belongs, providing shared protocols, research infrastructure, and best practices. While not a single competitor, it functions as the broader network peer shaping treatment standards, training, and competitive benchmarks in the same autologous adipose stem cell niche.
Direct peers
- StemGenex: StemGenex is a California-based regenerative medicine clinic offering autologous adipose-derived stem cell therapy for orthopedic, neurological, and autoimmune conditions. It is a direct competitor in the cash-pay stem cell clinic market with overlapping treatment menus and patient profiles.
- Bioxcellerator: Bioxcellerator is a stem cell therapy provider offering autologous and culture-expanded cell treatments for orthopedic, neurological, and chronic conditions. It competes directly with KRMC in the premium self-pay regenerative medicine market and targets medically minded international patients.
- Regenexx: Regenexx is the largest U.S. network of independent regenerative medicine clinics offering autologous stem cell and PRP treatments for orthopedic and spine conditions. It directly competes with KRMC for self-pay patients seeking surgery alternatives, using a similar autologous, same-day outpatient model.
- Dr. Lox Stem Cell & Sports Regenerative Medicine: Dr. Lox operates a Florida-based regenerative medicine practice specializing in autologous stem cell therapy for orthopedic and sports injuries. It directly overlaps KRMC's pro-athlete and joint-pain segments using the same adipose-derived autologous approach.
Others
- Predictive Biotech: Predictive Biotech is a Utah-based biologic supplier providing Wharton Jelly-derived allogeneic products and cell-processing services to regenerative medicine clinics. It is an ecosystem participant supplying inputs and competing technologies to clinics like KRMC.
Regional players
- Rejuv Medical: Rejuv Medical is a Midwest-based regenerative medicine and functional medicine practice offering stem cell and PRP therapies. As a similarly positioned regional peer serving overlapping Midwest patient demographics, it represents a comparable self-pay competitor outside Kansas.
Emerging players
- Personalized Stem Cells: Personalized Stem Cells focuses on FDA-compliant clinical research using autologous adipose-derived stem cells for orthopedic indications. It represents an emerging, more regulated peer that could compete with KRMC by offering trial-backed legitimacy in the same therapy class.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Kansas Regenerative Medicine Center social profiles
Digital presenceKansas Regenerative Medicine Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kansas Regenerative Medicine Center leadership team
Management profileNumber of profiles
Profiles9 records
Kansas Regenerative Medicine Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kansas Regenerative Medicine Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kansas Regenerative Medicine Center
What does Kansas Regenerative Medicine Center do?
Kansas Regenerative Medicine Center is a stand-alone regenerative medicine clinic that delivers same-day outpatient stem cell therapy using patients' own (autologous) adult mesenchymal stem cells derived from adipose (fat) tissue or bone marrow, often combined with platelet-rich plasma (PRP). Treatments target orthopedic, neurological, autoimmune, cardiac, pulmonary, and peripheral neuropathy conditions through image-guided injections under local anesthesia.
Is Kansas Regenerative Medicine Center a public or private company?
Kansas Regenerative Medicine Center is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Kansas Regenerative Medicine Center founded?
Kansas Regenerative Medicine Center was founded in 2014. It employs 11 to 50 people.
Where is Kansas Regenerative Medicine Center based?
Kansas Regenerative Medicine Center is headquartered in Manhattan, United States, in the North America region.
How does Kansas Regenerative Medicine Center make money?
One revenue line is on record: stem Cell Therapy Procedures.
Who are Kansas Regenerative Medicine Center's main competitors?
Broad incumbents on record are Cleveland Clinic Center for Regenerative Medicine, Hospital for Special Surgery (HSS) and Cell Surgical Network. Direct peers are StemGenex, Bioxcellerator, Regenexx and Dr. Lox Stem Cell & Sports Regenerative Medicine. Predictive Biotech is listed as an others. Rejuv Medical is listed as a regional player. Personalized Stem Cells is listed as an emerging player.
Does Kansas Regenerative Medicine Center have an API?
No public API is recorded for Kansas Regenerative Medicine Center.
What industry is Kansas Regenerative Medicine Center in?
Kansas Regenerative Medicine Center's product category is Regenerative Medicine. Its primary akta.pro industry code is HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived), with a secondary code of HLAMANAB, Platelet-Rich Plasma (PRP) & Blood-Derived Orthobiologics. Its SIC code is 8011.